P +61 881 284 061
Miriam Lynn Track Record
Dr. Miriam Lynn is a molecular biologist with more than 10 years of research experience in the fields of genetics, proteomics and immunology. She completed her PhD in Trinity College Dublin working in the field of parasitology. She continued her studies with a 3 year Post-Doctoral position with the University of British Columbia in Canada focusing on proteomic technologies including mass spectrometry and antibody production.
After this, Miriam Lynn returned to Ireland and took up a position in at the National Children's Research Centre working in paediatric oncology. In May 2011, she took up a position as Experienced Researcher in OncoMark working on a European Framework 7 funded project entitled RATHER which focuses on providing new rationalised therapy options for difficult-to-treat breast cancer subtypes. This position included a secondment as a More Experience Marie Curie Research Fellow at the Cancer Biology and Therapeutics Lab at University College Dublin.
Currently Miriam is working as EMBL Postdoctoral Fellow & Lab. Manager at SAMHRI where she is setting up the Infection and Immunity lab.
- Lynn, M.A., Shah, N., Conroy, J., Ennis, S., Morris, T., Betts, D., O’ Sullivan, M. (2014) “A Study of Alveolar Rhabdomyosarcoma Copy Number Alterations by Single Nucleotide Polymorphism Analysis”. Applied Immunohistochemistry & Molecular Morphology 22: 213-21.
- O’Hurley, G., Daly, E., O’Grady, A., Cummins, R., Lynn, M.A., Fan, Y., Rafferty, M., Fitzgerald, D., Pontén, F., Duffy, M.J., Jirström, K., Kay, E.W, Gallagher, W.M. (2014) “Investigation of Molecular Alterations of AKT-3 in Triple Negative Breast Cancer”. Histopathology64: 660-70.
- Lynn, M.A., Shah, N., Conroy, J., Ennis, S., Morris, T., Betts, D., Fletcher, J., O’ Sullivan, M. (2013) “Single Nucleotide Polymorphisms identify copy number variations in Ewing’s sarcoma cohort”. Diagnostic Molecular Pathology 22: 76-84.
- Lynn, M.A.,Marr, A.K., McMaster, W.R. (2013) “Quantitative differential proteomic analysis of membrane proteins in Leishmania infantum”. Journal of Proteomics 82:179-92.
- Lynn, M.A., Kindrachuk, J., Marr, A.K., Jenssen, H., Pante, N., Elliott, M., Napper, S., Hancock, R.E.W., McMaster, W.R. (2011) “Effect of protease resistance BMAP 28 antimicrobial peptides on GP63 protease-free Leishmania major strains“. PLoS Neglected Tropical Diseases 5:e1141.
- Silverman, J.M., Clos, J., Wang, A., Horakova, E., Wiesgigl, M., Kelly, I, Lynn, M.A., McMaster, W.R., Foster, L.J., Levings, M.K., Reiner, N.E. (2010) “Leishmania exosomes modulate innate and adaptive immune responses through effects on monocytes and dendritic cells”. Journal of Immunology 185: 5011-22.
- Murray, A., *Lynn, M.A., McMaster, W.R. (2010) “The Leishmania mexicana A600 genes are functionally required for amastigote replication”. Molecular and Biochemical Parasitology 172: 80-9. *(co-first author).
- Lynn, M.A., McMaster, W.R. (2008) “Leishmania: conserved evolution – diverse diseases.” Trends in Parasitology 24: 103-5.